Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Chronic kidney disease

Blood-pressure targets in chronic kidney disease

The optimal blood-pressure goals to prevent progression of chronic kidney disease (CKD) remain controversial. The results of the AASK cohort study provide additional support for more aggressive blood-pressure control (<130/90 mmHg) in proteinuric but not nonproteinuric patients with hypertensive CKD.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Differences in underlying pathology alter the threshold level of blood pressure that affects CKD progression.

References

  1. Appel, L. J. et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N. Engl. J. Med. 363, 918–929 (2010).

    Article  CAS  Google Scholar 

  2. Chobanian, A. V. et al. The seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 Report. JAMA 289, 2560–2572 (2003).

    Article  CAS  Google Scholar 

  3. Lewis, J. B. Blood pressure control in chronic kidney disease: is less really more? J. Am. Soc. Nephrol. 21, 1086–1092 (2010).

    Article  Google Scholar 

  4. Sarnak, M. J. et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann. Intern. Med. 142, 342–351 (2005).

    Article  Google Scholar 

  5. Bidani, A. K. & Griffin, K. A. Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension 44, 595–601 (2004).

    Article  CAS  Google Scholar 

  6. Griffin, K. A., Kramer, H. & Bidani, A. K. Adverse renal consequences of obesity. Am. J. Physiol. 294, F685–F696 (2008).

    CAS  Google Scholar 

  7. Hill, G. S. Hypertensive nephrosclerosis. Curr. Opin. Nephrol. Hypertens. 17, 266–270 (2008).

    Article  Google Scholar 

  8. The ESCAPE Trial Group. Strict blood-pressure control and progression of renal failure in children. N. Engl. J. Med. 361, 1639–1650 (2009).

  9. Ruggenenti, P. et al. Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomized controlled trial. Lancet 365, 939–946 (2005).

    Article  Google Scholar 

  10. Pogue, V. et al. Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension 53, 20–27 (2009).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anil K. Bidani.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bidani, A., Griffin, K. Blood-pressure targets in chronic kidney disease. Nat Rev Nephrol 7, 128–130 (2011). https://doi.org/10.1038/nrneph.2010.168

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2010.168

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing